drugset / Trial / NCT02737670
Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this prospective randomized and double blind controlled study is to evaluate the efficacy and safety of Sulodexide (25 mg) in the treatment of chronic idiopathic subjective tinnitus.
Timeline
- Start
- 2014-08
- Primary completion
- 2017-03
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sulodexide | Other / unclassified | 25 mg | — |